QURE Uniqure Nv

uniQure NV is engaged in the field of gene therapy platform across three therapeutic focus areas: Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.

$27.15  -0.28 (-1.02%)
As of 12/03/2021 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  The Netherlands
Country of incorporation:  The Netherlands
IPO date:  02/05/2014
Outstanding shares:  46,214,244
Average volume:  357,481
Market cap:   $1,267,656,713
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    N90064101
ISIN:        NL0010696654
Sedol:      BJFSR88
Valuation   (See tab for details)
PE ratio:   3.91
PB ratio:   2.12
PS ratio:   2.53
Return on equity:   54.28%
Net income %:   64.09%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy